Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Quality Update Reporting Changes under MACRA

Mary Beth Nierengarten  |  February 16, 2017

With the termination of the Sustainable Growth Rate formula through the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), clinicians who participate in Medicare Part B will now be reimbursed through a new payment model called the Quality Payment Program (QPP). How It Works The QPP rewards the delivery of high-quality patient care via…

Filed under:Practice SupportProfessional Topics Tagged with:Advanced Alternative Payment MethodMedicare Access and CHIP Reauthorization Act of 2015 (MACRA)Medicare Part BMIPSQuality Payment Program (QPP)Quality Update Reportingsustainable growth rate formula

ACR Urges CMMI to Test Transparently: Coalition offers principles to guide CMS’s care innovation efforts

Susan Bernstein  |  February 16, 2017

The Center for Medicare and Medicaid Innovation (CMMI), which develops concepts for healthcare payment and service delivery, must be transparent and engaged with all stakeholders as it tests new models, according to a coalition of 30 associations. On Feb. 10, the Healthcare Leaders for Accountable Innovation in Medicare Coalition, which includes the ACR, released six…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Center for Medicare and Medicaid Innovation (CMMI)CMMIguideline principlesHealthcare Leaders for Accountable Innovation in Medicare CoalitionMACRAMedicare Access and CHIP Reauthorization Act of 2015Quality Payment Program

Anti-Interleukin-6 Therapy for Erdheim-Chester Disease Warrants Study

Stefanie D. Wade, MD, Michael A. Seidman, MD, Edward C. Jones, MD, Arnold Radu, MD, Ryan Paterson, MD, Vikram Deshpande, MD, John H. Stone, MD, & Mollie N. Carruthers, MD  |  February 16, 2017

Erdheim-Chester disease (ECD) is a rare, non-Langerhan’s cell histiocytosis characterized by tissue infiltration of CD68-positive and CD1a-negative foamy histiocytes.1 ECD was discovered as a lipid granulomatosis in 1930 by Jakob Erdheim and his pupil, William Chester, and approximately 500 cases have been described to date.1 ECD has a heterogeneous course and prognosis ranging from an…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:anti-interleukincase reportClinicalDiagnosisDiseaseErdheim-ChesterinflammatoryinterferonPathogenesistherapyTreatment

Rheumatology Research Abstracts Highlight Treatment for Hand OA, Risk of Depression in Lupus and More

Mary Beth Nierengarten  |  February 15, 2017

WASHINGTON, D.C.—What do treating hand osteoarthritis (OA) in the primary care setting, high financial strain and risk of depression in patients with lupus, prolonged sitting and cardiovascular disease, and sex-specific treatment after total hip arthroplasty have in common? They were all topics presented during a session titled ARHP I: Exemplary Abstracts at the 2016 ACR/ARHP…

Filed under:ConditionsInsuranceMeeting ReportsResearch Rheum Tagged with:2016 ACR/ARHP Annual MeetingAssociation of Rheumatology Professionals (ARP)cardiovascularDepressionhandhealthcare costinsuranceLupusOAOsteoarthritispatient careResearchrheumatologistrheumatologyriskSLESystemic lupus erythematosustotal hip arthroplasty

Multispecialty Team Approach Key to Diagnosing, Treating Neutrophilic Dermatosis

Thomas R. Collins  |  February 15, 2017

WASHINGTON, D.C.—Often, no clear explanation exists in neutrophilic dermatosis cases that links a patient’s skin disorder with an internal condition, expert Joseph Jorizzo, MD, professor, founder and former chair of the Dermatology Department at Wake Forest University in Winston-Salem, N.C., and professor of clinical dermatology at Wevascularill Cornell Medical College in New York, told attendees…

Filed under:ConditionsMeeting Reports Tagged with:2016 ACR/ARHP Annual MeetingArthritisBehçet’s diseaseboweldermatosisDiagnosisneutrophilic vascular reactionsreactive diseaserheumatologistrheumatologySweet's syndromeTreatment

The ACR Supports Practicing Rheumatologists

Sharad Lakhanpal, MBBS, MD  |  February 14, 2017

A new presidential administration took office in January 2017. Although no one truly knows what directions our government and economy will take, one projection is that healthcare regulatory and insurance coverage policies will change, possibly dramatically. In a time of uncertainty, rheumatologists and rheumatology health professionals can turn to the ACR/ARHP for support, guidance and…

Filed under:Patient PerspectivePractice Support Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BillingCareerCodingEducationHealth Insurancephysician paymentrheumatologistrheumatologyRISE

Medical Records Don’t Always Match What Patients Say

Lisa Rapaport  |  February 2, 2017

(Reuters Health)—Symptoms that patients describe to doctors may not always be documented in electronic medical records, a small U.S. study suggests. To test out how well the records match reality, researchers compared symptoms that 162 patients checked off on paper-based questionnaires with the information entered in patients’ electronic charts at eye clinics. Roughly one-third of…

Filed under:EMRsTechnology

Biosimilar Update: ACR Says FDA Draft Guidance Is Promising & Biosimilar to Humira (Adalimumab) Enters Regulatory Review

Michele B. Kaufman, PharmD, BCGP  |  February 1, 2017

The ACR has released a statement, responding positively to the release of the latest U.S. Food and Drug Administration (FDA) draft guidance on biosimilar drug development. Also, BI 695501, a biosimilar to Humira (adalimumab) made by Boehringer Ingelheim, has been accepted for regulatory review in both the U.S. and Europe. ACR Responds to FDA Biosimilar…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabBI 695501BiosimilarsFDAFood and Drug AdministrationHumira

Full Circle: How Becoming an Educator Reenergized a Rheumatologist’s Career

Karen Appold  |  January 27, 2017

Career changes can be difficult. But for Stanford Shoor, MD, leaving clinical practice and becoming an educator in the field of rheumatology has been “a renaissance.”

Filed under:Career DevelopmentEducation & TrainingProfessional Topics Tagged with:CareerCareer developmentCareer satisfactionEducationeducation and trainingteaching

Why Keep a Seat at the AMA Table?

Kelly Tyrrell  |  January 18, 2017

As 2017 unfolds—a year when MACRA begins, lawmakers take steps to dismantle the health reform efforts of the past eight years, and political uncertainty is the rule—it is imperative that the ACR leverage its advocacy agenda by maintaining its seat at the American Medical Association’s (AMA’s) House of Delegates (HOD), says Gary Bryant, MD, FACP…

Filed under:Practice SupportProfessional Topics Tagged with:AMA House of Delegates (HOD)American Medical Association (AMA)RheumPAC

  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 126
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences